A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al..
2017.
Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.
A Wernicke G, Smith AW, Taube S, Yondorf MZ, Parashar B, Trichter S, Nedialkova L, Sabbas A, Christos P, Ramakrishna R et al..
2017.
Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.. J Neurosurg. 126(4):1212-1219.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..
2017.
Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..
2017.
Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
A Wernicke G, Hirschfeld CB, Smith AW, Taube S, Yondorf MZ, Parashar B, Nedialkova L, Kulidzhanov F, Trichter S, Sabbas A et al..
2017.
Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.. Int J Radiat Oncol Biol Phys. 98(5):1059-1068.
Fehlings MG, Tetreault LA, K Riew D, Middleton JW, Aarabi B, Arnold PM, Brodke DS, Burns AS, Carette S, Chen R et al..
2017.
A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.. Global Spine J. 7(3 Suppl):70S-83S.
Fehlings MG, Tetreault LA, K Riew D, Middleton JW, Aarabi B, Arnold PM, Brodke DS, Burns AS, Carette S, Chen R et al..
2017.
A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.. Global Spine J. 7(3 Suppl):70S-83S.
Fehlings MG, Tetreault LA, K Riew D, Middleton JW, Aarabi B, Arnold PM, Brodke DS, Burns AS, Carette S, Chen R et al..
2017.
A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.. Global Spine J. 7(3 Suppl):70S-83S.
Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, Zhang Y, Yao Y, Gillen KM, Wilman AH et al..
2017.
Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.. J Magn Reson Imaging. 46(4):951-971.
Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, Zhang Y, Yao Y, Gillen KM, Wilman AH et al..
2017.
Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.. J Magn Reson Imaging. 46(4):951-971.
M Janjua B, Caruso JP, Greenfield JP, Souweidane MM, Schwartz TH.
2017.
The combined transpetrosal approach: Anatomic study and literature review.. J Clin Neurosci. 41:36-40.
M Janjua B, Caruso JP, Greenfield JP, Souweidane MM, Schwartz TH.
2017.
The combined transpetrosal approach: Anatomic study and literature review.. J Clin Neurosci. 41:36-40.
Singh H, Essayed WI, Jada A, Moussazadeh N, Dhandapani S, Rote S, Schwartz TH.
2017.
Contralateral supraorbital keyhole approach to medial optic nerve lesions: an anatomoclinical study.. J Neurosurg. 126(3):940-944.
Singh H, Essayed WI, Jada A, Moussazadeh N, Dhandapani S, Rote S, Schwartz TH.
2017.
Contralateral supraorbital keyhole approach to medial optic nerve lesions: an anatomoclinical study.. J Neurosurg. 126(3):940-944.
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H et al..
2017.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.. Neurosurgery. 80(4):590-601.
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H et al..
2017.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.. Neurosurgery. 80(4):590-601.
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H et al..
2017.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.. Neurosurgery. 80(4):590-601.
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H et al..
2017.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.. Neurosurgery. 80(4):590-601.
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H et al..
2017.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.. Neurosurgery. 80(4):590-601.
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H et al..
2017.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.. Neurosurgery. 80(4):590-601.